Transplant, Autologous

DRUG2 trials

Sponsors

Peking University, First Affiliated Hospital of Zhejiang University

Conditions

Minimal Residual DiseaseMultiple MyelomaPeripheral T Cell Lymphoma

Unknown Phase

The Role of Consolidative Autologous Stem Cell Transplantation After First-line Therapy in Peripheral T Cell Lymphoma

Peking UniversityPeripheral T Cell Lymphoma

Start: 2020-11-30End: 2025-11-30Target: 60Updated: 2020-12-04

Primary Multiple Myeloma Who Achieved MRD Negativity After Induction Therapy, ASCT or Not

RecruitingNCT06463717

First Affiliated Hospital of Zhejiang UniversityMinimal Residual Disease, Multiple Myeloma

Start: 2023-12-01End: 2028-12-31Target: 210Updated: 2024-06-24